# Dysbindin-antipsychotics Psychophamarcogenetics: a Mouse-human Translational Study Towards Personalized Healthcare in Bipolar Disorders

> **NCT06167577** · — · COMPLETED · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 150 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DIAGNOSTIC_TEST:** Psychometric scales (BPRS, MRS, HAM-D, SES, and GAF) monthly

## Key facts

- **NCT ID:** NCT06167577
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-08
- **Primary completion:** 2022-02-08
- **Final completion:** 2023-11-08
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2024-12-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06167577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06167577, "Dysbindin-antipsychotics Psychophamarcogenetics: a Mouse-human Translational Study Towards Personalized Healthcare in Bipolar Disorders". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06167577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*